0000890821-22-000001.txt : 20220805
0000890821-22-000001.hdr.sgml : 20220805
20220805153528
ACCESSION NUMBER: 0000890821-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220805
DATE AS OF CHANGE: 20220805
EFFECTIVENESS DATE: 20220805
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enveric Biosciences, Inc.
CENTRAL INDEX KEY: 0000890821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954484725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-455082
FILM NUMBER: 221140503
BUSINESS ADDRESS:
STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200
CITY: NAPLES
STATE: FL
ZIP: 34103
BUSINESS PHONE: 239-302-1707
MAIL ADDRESS:
STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200
CITY: NAPLES
STATE: FL
ZIP: 34103
FORMER COMPANY:
FORMER CONFORMED NAME: AMERI Holdings, Inc.
DATE OF NAME CHANGE: 20150527
FORMER COMPANY:
FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC
DATE OF NAME CHANGE: 19950323
D
1
primary_doc.xml
X0708
D
LIVE
0000890821
Enveric Biosciences, Inc.
4851 TAMIAMI TRAIL N, SUITE 200
NAPLES
FL
FLORIDA
34103
239-302-1707
DELAWARE
AMERI Holdings, Inc.
SPATIALIZER AUDIO LABORATORIES INC
Corporation
true
Joseph
Tucker, PhD
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
Director
Chief Executive Officer and Director
David
Johnson
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
Director
Chairman
Carter
Ward
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
Chief Financial Officer
Avani
Kanubaddi
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
President and Chief Operating Officer
George
Kegler
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Sol
Mayer
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Dr. Bob
Dagher
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
Chief Medical Officer
Peter
Facchini, PhD
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
Chief Innovation Officer
Dr. Douglas
Lind
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Dr. Marcus
Schabacker
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Frank
Pasqualone
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Bevin
O'Niel
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Michael
D.
Webb
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2022-07-22
false
true
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 Park Avenue
3rd Floor
New York
NY
NEW YORK
10022
FL
FLORIDA
NY
NEW YORK
false
8617500
8617500
0
Includes 625K shares (or pre-funded warrants) and warrants to buy up to 625K shares at $8.00 per share and warrant for 1 share; warrants to buy up to 375K shares exercise price $7.78/share; 70K placement agent warrants, exercise price $10.00/share.
false
2
790950
0
PA received the above cash fee (including certain expense reimbursement) and 70K PA warrants, exercise price $10.00/share (not included in above cash fee) in connection with private placement and a concurrent RD offering (not reported on this Form D).
0
false
Enveric Biosciences, Inc.
Carter Ward
Carter Ward
Chief Financial Officer
2022-08-05